Insulet Common Stock share price logo

Insulet Common Stock

NASDAQ: PODD

Mid Cap

$148.88

+4.98

(+3.46%)

as on

Insulet Common Stock Stock Performance

as on June 25, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $144.88
    $149.56
    downward going graph

    2.69%

    Downside

    0.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $138.79
    $354.88
    downward going graph

    6.78%

    Downside

    138.37%

    Upside

    downward going graph

Insulet Common Stock share price movements today

Previous Close
$143.90
Open
$145.00
Volume
933.2K
Day's Low - High
$144.88 - $149.56
52 Week Low - High
$138.79 - $354.88

Insulet Common Stock Historical Returns

1 Month Return
-3.87 %
3 Month Return
-31.07 %
1 Year Return
-51.38 %
3 Year Return
-48.28 %
5 Year Return
-46.51 %

Insulet Common Stock Stock Fundamentals & Key Indicators

Check Insulet Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.0B

EPS (TTM)

6.4812

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.59%

PE Ratio (TTM)

33.62

Industry PE ratio

15.0325

PEG Ratio

1.2262

EBITDA

602.0M

Revenue (TTM)

2.9B

Profit Margin

10.44%

Return On Equity TTM

23.00%

Insulet Common Stock Stock Valuation

Track how Insulet Common Stock P/E has moved over time to understand its valuation trends.

Insulet Common Stock in the last 5 years

  • Overview

  • Trends

Lowest (47.78x)

March 31, 2026

Industry (15.03x)

June 25, 2026

Today (33.62x)

June 25, 2026

Highest (143.53x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 33.62x

Insulet Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insulet Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$10.0B-46.51%33.6210.44%NA
BUY$118.8B19.27%35.8413.21%1.13%
BUY$50.1B-13.43%46.517.39%NA
BUY$103.2B-35.86%21.6213.20%3.58%
BUY$67.8B0.82%19.0817.29%NA

Stock Returns calculator for Insulet Common Stock Stock including INR - Dollar returns

The Insulet Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Insulet Common Stock investment value today

Current value as on today

₹53,551

Returns

-₹46,449

(-46.45%)

Returns from Insulet Common Stock Stock

-₹51,383 (-51.38%)

Dollar Impact

₹4,934 (+4.93%)

Analyst Recommendation on Insulet Common Stock Stock

Based on 28 analysts

BUY

82.14%

Buy

17.86%

Hold

0.00%

Sell

Based on 28 analysts, 82.14% of analysts recommend a 'BUY' rating for Insulet Common Stock. Average target price of $242.43

Insulet Common Stock Share Price Target

Get share price movements and forecasts by analysts on Insulet Common Stock.

What analysts predicted

38.59%UPSIDE

Target Price

$242.43

Current Price

$148.88

Analyzed by

28 Analysts

Target

$242.43

Insulet Common Stock target price $242.43, a slight upside of 38.59% compared to current price of $148.88. According to 28 analysts rating.

Indian Investors' Interest in Insulet Common Stock Stock

Search interest for Insulet Common Stock Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Insulet Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
509
441
488
543
597
569
649
706
783
761
Gross Profit
361
306
330
377
430
409
452
510
568
529
Operating Income
106
56
54
88
109
88
121
117
146
122
EBITDA
133
84
81
116
141
79
70
160
190
153
Interest Expense
6
10
11
12
8
9
19
15
19
14
Depreciation
18
18
19
21
21
21
22
22
24
26
Income Before Tax
107
54
51
82
111
48
28
122
140
113
Income Tax Expense
4
3
-137
5
10
12
5
35
38
21
Net Income
103
51
188
77
100
35
22
87
101
91
Net Profit Margin
20.26%
11.66%
38.61%
14.25%
16.85%
6.22%
3.47%
12.40%
12.96%
11.96%

Insulet Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
366
463
563
738
904
1,098
1,305
1,697
2,071
2,708
Gross Profit
211
277
370
480
582
752
805
1,159
1,445
1,939
Operating Income
-10
-7
27
50
51
126
37
220
308
473
EBITDA
1
6
43
74
110
139
109
323
423
532
Interest Expense
14
19
22
34
48
61
36
36
42
79
Depreciation
-
13
15
27
55
57
63
70
80
90
Income Before Tax
-26
-26
5
14
9
20
9
214
300
339
Income Tax Expense
0
0
1
2
2
3
5
8
-118
92
Net Income
-28
-26
3
11
6
16
4
206
418
247
Net Profit Margin
-7.87%
-5.79%
0.58%
1.57%
0.75%
1.53%
0.35%
12.16%
20.19%
9.12%

Insulet Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
51
188
77
100
35
22
87
101
91
Operating Cash Flow
87
86
98
147
63
196
125
183
113
Investing Cash Flow
-24
-24
-29
-68
-15
-23
-31
-152
-27
Financing Cash Flow
-14
8
7
-20
277
-343
-456
-72
-319
Change in Cash
47
69
81
50
329
-161
-364
-41
-235

Insulet Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
3
11
6
16
4
206
418
247
Operating Cash Flow
41
35
98
84
-68
119
145
430
569
Investing Cash Flow
-210
-184
-73
14
-82
-191
-119
-146
-222
Financing Cash Flow
304
-8
73
605
40
-40
-13
-28
-595
Change in Cash
135
-158
99
708
-115
-116
14
249
-237

Mutual Funds that own Insulet Common Stock Stock

Check out the Mutual Funds with significant holdings in Insulet Common Stock.

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.01554%
517

Global Institutional Holdings in Insulet Common Stock

Funds
Holdings
Federated Hermes Inc
1.11%
Geode Capital Management, LLC
2.92%
Capital Research Global Investors
2.41%
ClearBridge Advisors, LLC
1.91%
UBS Asset Mgmt Americas Inc
1.15%

Insulet Common Stock News & Key Events

  • img

    Today's Timeline - 01 June

    Mon, 01:12 PM

    -

    U.S. appeals court overturns $59.4 million award to Insulet against EOFlow for trade secrets theft.

    Mon, 07:44 PM

    -

    Insulet initiates voluntary correction for Omnipod devices due to manufacturing issues affecting insulin delivery.

Insights on Insulet Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 16.5% return, outperforming this stock by 67.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insulet Corporation Common Stock has experienced a drawdown of -48.3%, however Stryker Corporation resisted the overall trend and outperformed by 47.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 783.8M → 761.7M (in $), with an average decrease of 2.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 101.6M → 91.1M (in $), with an average decrease of 10.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PODD stock has moved down by -31.1%

About Insulet Common Stock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
OrganisationInsulet Common Stock
Headquarters100 Nagog Park, Acton, MA, United States, 01720
IndustryMedical Devices
CEOMs. Ashley A. McEvoy
E-voting on sharesClick here to vote

Key Management of Insulet Common Stock

Name

Title

Mr. Eric Benjamin

Executive VP & COO

Mr. Prem Singh

Senior Vice President of Global Operations

Mr. Amit Guliani

Senior VP & CTO

Mr. Chuck Medovich

Senior VP and Chief Quality, Regulatory & Compliance Officer

Ms. Ashley A. McEvoy

CEO, President & Director

Ms. Flavia H. Pease

Executive VP & CFO

Mr. John Wodick Kapples J.D.

Senior VP & General Counsel

Ms. Clare Trachtman

Vice President of Investor Relations

Ms. Angela Geryak Wiczek

Senior Director of Corporate Communications

Mr. Philip Hildale

Senior Vice President of Sales & Customer Care

FAQs

What is Insulet Common Stock share price today?

Insulet Common Stock share price today is $148.88 as on at the close of the market. Insulet Common Stock share today touched a day high of $149.56 and a low of $144.88.

What is the 52 week high and 52 week low for Insulet Common Stock share?

Insulet Common Stock share touched a 52 week high of $354.88 on and a 52 week low of $138.79 on . Insulet Common Stock stock price today i.e. is closed at $148.88,which is 58.05% down from its 52 week high and 7.27% up from its 52 week low.

What is Insulet Common Stock's market capitalisation today?

Insulet Common Stock market capitalisation is $0.01T as on .

How to invest in Insulet Common Stock Stock (PODD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Insulet Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insulet Common Stock Shares that will get you 0.0101 shares as per Insulet Common Stock share price of $148.88 per share as on June 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy Insulet Common Stock Stock (PODD) from India?

Indian investors can start investing in Insulet Common Stock (PODD) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Insulet Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Insulet Common Stock share’s latest price of $148.88 as on June 25, 2026 at 8:46 am IST, you will get 0.0672 shares of Insulet Common Stock. Learn more about fractional shares .

What are the returns that Insulet Common Stock has given to Indian investors in the last 5 years?

Insulet Common Stock stock has given -46.51% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?